S100A11 was observed to be highly expressed in pancreatic ductal adenocarcinoma (PDAC) tissues and demonstrated a significant association with poorer prognosis and disease progression [26]. This evidence concerns the gene S100A11 and pancreatic ductal adenocarcinoma.